Global Health Ltd.
MEDANTA · NSE · Healthcare
With a 20% margin of safety, our buy-below price is ₹769.79.
Piotroski F-score 4/9 — quality of earnings & balance sheet.
Investability checklist
- ✓ROE above 15%15.0%
- ✓Low debt (D/E < 0.5)0.30x
- ✕Positive free cash flow
- ✓Revenue growth > 10%25%
- ✓Earnings growing42%
- ✓Net margin ≥ 10%12.6%
- ✓Current ratio > 1.52.67
- ✕Below our fair value
- ✕Margin of safety ≥ 20%
- ✓Above 200-day average
- ✓Above 50-day average
- –Positive 1-year return
- ✓Altman Z in safe zoneZ 11.73
- ✕Piotroski ≥ 74/9
1-year price
EOD · 2026-06-15Our scores
Key fundamentals
SWOT snapshot
Strengths
- •Lightly leveraged balance sheet.
- •Financially solid — Altman Z 11.73.
Opportunities
- •Earnings growing (42% YoY).
- •Revenue growing (25% YoY).
Threats
- •Trades ~21% above our estimated fair value.
About Global Health Ltd.
Global Health Limited, together with its subsidiaries, provides healthcare services in India. The company offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, emergency, ENT, head and neck surgery, internal medicine, respiratory and sleep medici
More in Healthcare
Our verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.